LYMPHATIC TARGETING OF ANTI-HIV NUCLEOSIDES - DISTRIBUTION OF 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) AND 3'-AZIDO-2',3'-DIDEOXYURIDINE (AZDU) AFTER ADMINISTRATION OF DIPALMITOYLPHOSPHATIDYL PRODRUGS TO MICE
Kk. Manouilov et al., LYMPHATIC TARGETING OF ANTI-HIV NUCLEOSIDES - DISTRIBUTION OF 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) AND 3'-AZIDO-2',3'-DIDEOXYURIDINE (AZDU) AFTER ADMINISTRATION OF DIPALMITOYLPHOSPHATIDYL PRODRUGS TO MICE, Antiviral chemistry & chemotherapy, 6(4), 1995, pp. 230-238
Human immunodeficiency virus appears to be proliferating within the ly
mphatic system throughout the period of clinical latency. Targeting of
anti-HIV compounds to the lymphatic tissue may therefore provide ther
apeutic benefits. The purpose of this investigation was to determine t
he distribution of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'
-dideoxyuridine (AZdU) in lymph nodes in a mouse model after administr
ation of the lipophilic prodrugs dipalmitoylphosphatidyl-azidodeoxythy
midine (DPP-AZT) and dipalmitoylphosphatidyl-azidodideoxyuridine (DPPA
ZdU). Mice received 50 mg kg(-1) of parent nucleoside and 164 mg kg(-1
) of DPP-AZT (equivalent to 50 mg kg(-1) AZT) intravenously or orally
and 180 mg kg(-1) DPPAZdU (equivalent to 50 mg kg(-1) AZdU) orally. Se
rum, neck, axillary and mesenteric lymph nodes were collected at selec
ted times and AZT and AZdU concentrations were determined by HPLC. The
disposition of AZT and AZdU in serum and lymph nodes was significantl
y altered after intravenous and oral administration of DPP-AZT and ora
l administration of DPP-AZdU when compared to that after administratio
n of parent nucleoside. Lower peak concentrations of AZT and AZdU were
observed in serum and lymph nodes after administration of the phospho
lipid prodrugs. However, DPP-AZT and DPP-AZdU produced consistently hi
gher concentrations of AZT and AZdU, respectively, 2-3 h after prodrug
administration. Half-life values for both nucleosides in serum and ly
mph nodes were significantly greater after prodrug administration. Gre
ater AUC values for nucleosides were noted in neck (AZT and AZdU) and
mesenteric (AZT) lymph nodes after administration of prodrugs compared
with values obtained for parent drugs. Furthermore, relative lymph no
de exposure to AZT and AZdU in the lymph nodes was greater after admin
istration of prodrug than after administration of parent compound. Thu
s, DPP-AZT and DPP-AZdU show potential as useful prodrugs for the deli
very of AZT and AZdU to the lymphatic system.